Arcellx (ACLX) Cash from Financing Activities (2021 - 2025)

Arcellx (ACLX) recorded quarterly Cash from Financing Activities of $1.6 million in Q4 2025, down 98.1% quarter-over-quarter from $86.1 million in Q3 2025, and up 127.16% on a YoY basis from $719328.2 in Q4 2024.

Arcellx (ACLX) Cash from Financing Activities (2021 - 2025) Analysis & Trends

Arcellx's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.

  • In Q4 2025, Cash from Financing Activities rose 127.16% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $98.5 million (up 509.08% YoY), while the FY2025 annual figure was $98.5 million, up 509.08% from the prior year.
  • Cash from Financing Activities was $1.6 million for Q4 2025 at Arcellx, down from $86.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $188.6 million in Q4 2023 to a low of -$10.4 million in Q2 2024.
  • Historically, Cash from Financing Activities has averaged $36.2 million across 5 years, with a median of $928500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 14252.44% in 2023, then slumped 9088.79% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $15000.0 in 2021, then surged by 8660.0% to $1.3 million in 2022, then soared by 14252.44% to $188.6 million in 2023, then sank by 103.19% to -$6.0 million in 2024, then surged by 127.16% to $1.6 million in 2025.
  • The last three Cash from Financing Activities figures came in at $1.6 million (Q4 2025), $86.1 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Arcellx 6.48 Bn 6.48 Bn - 1.63 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.63 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 86.10 Mn
Sep 30, 2025 86.10 Mn
Jun 30, 2025 10.26 Mn
Jun 30, 2025 10.26 Mn
Mar 31, 2025 543,000.00
Mar 31, 2025 543,000.00
Dec 31, 2024 -6.02 Mn
Dec 31, 2024 -6.02 Mn
Sep 30, 2024 -4.66 Mn
Sep 30, 2024 -4.66 Mn
Jun 30, 2024 -10.43 Mn
Jun 30, 2024 -10.43 Mn
Mar 31, 2024 -2.99 Mn
Mar 31, 2024 -2.99 Mn
Dec 31, 2023 188.59 Mn
Dec 31, 2023 188.59 Mn
Sep 30, 2023 -4.99 Mn
Sep 30, 2023 -4.99 Mn